Selection of topoisomerase mutations and overexpression of adeB mRNA transcripts during an outbreak of Acinetobacter baumannii

被引:93
作者
Higgins, PG [1 ]
Wisplinghoff, H [1 ]
Stefanik, D [1 ]
Seifert, H [1 ]
机构
[1] Univ Cologne, Inst Med Microbiol Immunol & Hyg, D-50935 Cologne, Germany
关键词
ciprofloxacin; efflux; RT-PCR; multidrug resistance;
D O I
10.1093/jac/dkh427
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate the mechanism of ciprofloxacin resistance in isolates of Acinetobacter baumannii during two hospital outbreaks and to determine the expression level of the gene encoding the AdeB efflux pump. Methods: Isolates were previously typed by PFGE and their MICs determined by broth microdilution. The gyrA and parC genes were sequenced and the adeB gene examined by real-time reverse transcription PCR (RT-PCR). Results: Two clonal lineages were responsible for the two hospital outbreaks. In both outbreaks, ciprofloxacin susceptibility was reduced during the course of the outbreak when compared with the index isolates. Mutations in gyrA and parC were found to have occurred during the outbreak. The MICs of non-fluoroquinolone antibiotics were raised in one clonal lineage and this was associated with a >10-fold increase in mRNA transcripts for adeB. Conclusions: We have witnessed the appearance of gyrA and parC mutations during outbreaks of A. baumannii. In parallel with these mutations, we observed up-regulation of the adeB gene associated with a decrease in susceptibility to non-fluoroquinolone antibiotics. These data illustrate the propensity for A. baumannii to develop multi-drug resistance rapidly.
引用
收藏
页码:821 / 823
页数:3
相关论文
共 10 条
  • [1] Brief report: Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Davidson, R
    Cavalcanti, R
    Brunton, JL
    Bast, DJ
    de Azavedo, JCS
    Kibsey, P
    Fleming, C
    Low, DE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (10) : 747 - 750
  • [2] Molecular mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients
    Jalal, S
    Ciofu, O
    Hoiby, N
    Gotoh, N
    Wretlind, B
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 710 - 712
  • [3] Survival of Acinetobacter baumannii on dry surfaces:: Comparison of outbreak and sporadic isolates
    Jawad, A
    Seifert, H
    Snelling, AM
    Heritage, J
    Hawkey, PM
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (07) : 1938 - 1941
  • [4] Antibiotic resistance is a major risk factor for epidemic behavior of Acinetobacter baumannii
    Koeleman, JGM
    van der Bijl, MW
    Stoof, J
    Vandenbroucke-Grauls, CMJE
    Savelkoul, PHM
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2001, 22 (05) : 284 - 288
  • [5] Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454
    Magnet, S
    Courvalin, P
    Lambert, T
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (12) : 3375 - 3380
  • [6] National Committee for Clinical Laboratory Standards, 2000, METH DIL ANT SUSC TE
  • [7] Collateral damage from cephalosporin or quinolone antibiotic therapy
    Paterson, DL
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 : S341 - S345
  • [8] COMPARISON OF RIBOTYPING AND PULSED-FIELD GEL-ELECTROPHORESIS FOR MOLECULAR TYPING OF ACINETOBACTER ISOLATES
    SEIFERT, H
    GERNERSMIDT, P
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (05) : 1402 - 1407
  • [9] Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
    Vila, J
    Ruiz, J
    Goni, P
    deAnta, TJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (06) : 757 - 762
  • [10] Nosocomial Acinetobacter baumannii infections:: Microbiological and clinical epidemiology
    Villers, D
    Espaze, E
    Coste-Burel, M
    Giauffret, F
    Ninin, E
    Nicolas, F
    Richet, H
    [J]. ANNALS OF INTERNAL MEDICINE, 1998, 129 (03) : 182 - +